User profiles for Hend Ahmed El-Hadaad
Hend Ahmed El-HadaadMansoura University Verified email at mans.edu.eg Cited by 903 |
[HTML][HTML] Current approaches in treatment of triple-negative breast cancer
HA Wahba, HA El-Hadaad - Cancer biology & medicine, 2015 - ncbi.nlm.nih.gov
Triple-negative breast cancer (TNBC) is diagnosed more frequently in younger and premenopausal
women and is highly prevalent in African American women. TNBC is a term derived …
women and is highly prevalent in African American women. TNBC is a term derived …
[HTML][HTML] Adjuvant Pelvic Radiotherapy vs. Sequential Chemoradiotherapy for High-Risk Stage I-II Endometrial Carcinoma
Objective To explore if the addition of adjuvant chemotherapy with paclitaxel and carboplatin
to radiotherapy confers an advantage for overall survival (OAS), and progression free …
to radiotherapy confers an advantage for overall survival (OAS), and progression free …
Immunohistochemical expression and prognostic relevance of Bmi-1, a stem cell factor, in epithelial ovarian cancer
HA El-Hadaad - Annals of diagnostic pathology, 2014 - Elsevier
Ovarian cancer is the fourth most common cause of cancer-related death in women. Bmi-1
is a stem cell factor implicated in many human malignancies with poor outcome. Few …
is a stem cell factor implicated in many human malignancies with poor outcome. Few …
[HTML][HTML] Radiotherapy versus stenting in treating malignant dysphagia
H Eldeeb, HA El-Hadaad - Journal of Gastrointestinal Oncology, 2012 - ncbi.nlm.nih.gov
The most commonly used treatments for maliganat dysphagia are stenting and radiotherapy
(RT). A prospective data of 91 patients with locally advanced or metastatic esophageal …
(RT). A prospective data of 91 patients with locally advanced or metastatic esophageal …
Pathophysiology, mechanism, and outcome of ischemic stroke in cancer patients
M Abdelsalam, M Abu-Hegazy, HA El-Hadaad… - Journal of stroke and …, 2020 - Elsevier
Objectives The purpose of this study is to assess the risk factors, biomarkers of stroke,
mechanism, and outcomes of cerebral infarction among cancerous diseases. Materials & Methods …
mechanism, and outcomes of cerebral infarction among cancerous diseases. Materials & Methods …
Oxaliplatin plus 5-fluorouracil and folinic acid (OFF) in gemcitabine-pretreated advanced pancreatic cancer: a phase II study
HA El-Hadaad, HA Wahba - Journal of gastrointestinal cancer, 2013 - Springer
Background Despite median survival of less than 6 months, there is a significant proportion
of advanced pancreatic cancer patients who progress on gemcitabine that remains fit, and …
of advanced pancreatic cancer patients who progress on gemcitabine that remains fit, and …
Neoadjuvant concurrent chemoradiotherapy with capecitabine and oxaliplatin in patients with locally advanced esophegeal cancer
HA Wahba, HA El-Hadaad, EA Abd-Ellatif - Medical Oncology, 2012 - Springer
Abstract Evaluation of the feasibility and efficacy of neoadjuvant concurrent chemoradiotherapy
(CRT) with capecitabine and oxaliplatin in patients with locally advanced esophageal …
(CRT) with capecitabine and oxaliplatin in patients with locally advanced esophageal …
Metastatic esophageal carcinoma: prognostic factors and survival
Background Worldwide, esophageal cancer is the eighth most common cancer and the
sixth leading cause of cancer-related death. At initial diagnosis, about 50% of esophageal …
sixth leading cause of cancer-related death. At initial diagnosis, about 50% of esophageal …
Concomitant chemoradiotherapy using low-dose weekly gemcitabine versus low-dose weekly paclitaxel in locally advanced head and neck squamous cell carcinoma …
The objective of this study was to compare concomitant chemoradiotherapy based on weekly
low-dose gemcitabine versus weekly low-dose paclitaxel in locally advanced head and …
low-dose gemcitabine versus weekly low-dose paclitaxel in locally advanced head and …
Neurocognitive effects of primary brain tumors
M Abu-Hegazy, HA El-Hadaad - … Newer Developments. InTech, 2016 - books.google.com
Cognitive impairment, a common finding with the brain tumors, may result from the tumor
itself or the treatment used: surgery, chemotherapy, or radiotherapy. Surgery for brain tumors …
itself or the treatment used: surgery, chemotherapy, or radiotherapy. Surgery for brain tumors …